cGMP-dependent protein kinase modulators.
1Institute of Clinical Biochemistry, University of Wuerzburg, Grombuehlstrasse 12, Wuerzburg, 97080, Germany. butt@klin-biochem.uni-wuerzburg.de
Handbook of Experimental Pharmacology
|December 18, 2008
Summary
This review proposes a framework for evaluating cyclic nucleotide-dependent protein kinase (PKG) activators and inhibitors. It discusses PKG signal transduction and challenges with current modulators for broader application.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- cGMP-dependent protein kinase (PKG) modulators have been studied for nearly 30 years.
- Over 200 PKG modulators synthesized, but few have achieved widespread use.
- Understanding PKG signaling is crucial for therapeutic development.
Purpose of the Study:
- To propose a framework for evaluating and utilizing PKG activators and inhibitors.
- To explore and interpret PKG signal transduction in cell culture models.
- To address challenges in PKG modulator development and application.
Main Methods:
- Review of existing literature on PKG modulators and signaling pathways.
- Analysis of cGMP-analog cross-reactivity with other cyclic nucleotide-binding proteins.
- Discussion of advantages and limitations of novel PKG inhibitors.
Main Results:
- A framework for PKG modulator evaluation is suggested.
- Cross-reactivity issues with cGMP analogs are highlighted.
- Challenges with newly designed PKG inhibitors are identified.
Conclusions:
- A systematic approach is needed to improve the application of PKG modulators.
- Further research into PKG signal transduction and inhibitor design is warranted.
- Optimizing PKG modulators could unlock new therapeutic applications.
More Related Videos
Related Concept Videos
cAMP-dependent Protein Kinase Pathways
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
GPCRs Regulate Adenylyl Cylase Activity
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Two...
Calmodulin-dependent Signaling
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Activation and Inactivation of G Proteins
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high affinity and are together...
GTPases and their Regulation
Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒ small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins, also known...
Large G-proteins, also known...


